Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 78 of 100
This Is the First Time Two Category 4 Hurricanes Have Made U.S. Landfall In a Single Season
By
Sy Mukherjee
Health
Botox Maker Allergan’s CEO Defends Selling Drug Patents to Native American Tribe to Thwart Rivals
By
Sy Mukherjee
Health
Brainstorm Health: Tom Brokaw on His Health, Fitbit Diabetes Deal, Pfizer Epipen Site Flaws
By
Clifton Leaf
and
Sy Mukherjee
Health
This GIF Shows Just How Much More Powerful Hurricane Irma Is Than Hurricane Andrew
By
Sy Mukherjee
Health
Brainstorm Health: Lasker Prize Winners, Dental Augmented Reality, Opioids and the Labor Force
By
Clifton Leaf
and
Sy Mukherjee
Health
Drugs Are Why 1 in 5 Men Drop Out of the Labor Market
By
Sy Mukherjee
Health
These Hurricane Irma Myths Have Gone Viral. Don’t Fall for Them
By
Sy Mukherjee
Health
This Controversial Biotech May Yet Defy Its Skeptics
By
Sy Mukherjee
Health
Brainstorm Health: Sarepta Stock Spikes, Zika for Brain Cancer, Lasker Prize Winners
By
Clifton Leaf
and
Sy Mukherjee
Health
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By
Sy Mukherjee
Health
Brainstorm Health: Novartis Cancer Drug Price, Rare Disease Film Festival, Harvey and Houston Hospitals
By
Clifton Leaf
and
Sy Mukherjee
Health
Brainstorm Health: Elon Musk and AI, Novartis CAR-T Approved, Instagram Plastic Surgeons
By
Clifton Leaf
and
Sy Mukherjee
Health
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By
Sy Mukherjee
Health
Brainstorm Health: Hospitals and Harvey, VR Dementia Research, Stem Cell ‘Bad Actors’
By
Clifton Leaf
and
Sy Mukherjee
Health
How Hospitals Prepare for a Hurricane Like Harvey
By
Sy Mukherjee